Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Firms/KBW
KBW

KBW

21 tracked analysts · 616 measured calls · pooled track record
57%
Pooled Success Rate
+5.7%
Avg Return / Call
-6.6%
vs S&P 500
21
Analysts Tracked

These figures pool every individual call made by KBW's analysts into a single sample — so a prolific analyst carries more weight than a low-volume one, exactly in proportion to the evidence available. All metrics are computed independently by 13Foresight from historical prices.

KBW — Analyst Roster & Track Records 21 analysts · top 6 Pro-only
Analyst Our Rank Stars Success Avg Return vs S&P Calls
Pro analyst
Pro analyst
Pro analyst
Pro analyst
Pro analyst
Pro analyst
Kelly Motta #485 ★★★★ 65% +3.8% -3.2% 31
Meyer Shields #543 ★★★★ 68% +5.2% -2.6% 44
Wood Lay #571 ★★★★ 63% +1.7% -4.4% 30
Alex Bond #801 ★★★ 60% +0.1% -4.9% 10
Thomas McJoynt Griffith #952 ★★★ 56% +1.1% -5.5% 16
Paul Johnson #1058 ★★★ 58% -0.7% -7.7% 33
Catherine Mealor #1429 ★★★ 47% +2.2% -6.2% 30
Ryan Tomasello #1502 ★★★ 35% +30.0% +25.3% 17
Jade Rahmani #1597 ★★★ 42% -1.5% -5.8% 31
Bose George #1722 ★★★ 41% +2.7% -4.6% 41
Vasundhara Govil #1747 ★★★ 36% -2.1% -10.0% 14
Kyle Voigt #2256 ★★ 40% -2.9% -18.0% 35
Sanjay Sakhrani #2351 32% -4.2% -15.8% 38
Christopher Allen #2359 30% -7.8% -15.4% 30
Thomas Hallett 0% -47.5% -60.8% 2
🔒 The 6 highest-rated analysts at KBW are Pro-only — this is where the real edge is. Reveal top 6

🔓 What 13Foresight Pro unlocks here

The 6 top-ranked analysts at KBW, the firm's full 3- and 5-year track record, and firm-vs-firm rankings across Wall Street. Everything below the top 6, plus 1- and 2-year history, stays free — Pro is what keeps this independent research running and the servers paid for.

Upgrade to Pro

Disclaimer: Firm-level performance is calculated independently by 13Foresight by pooling the historical calls of analysts associated with this firm, measured against market prices. It may be incomplete or delayed, is for research purposes only, and is not investment advice.